Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators

Background: In the scope of the European Commission Initiative on Breast Cancer (ECIBC) the Monitoring and Evaluation (M&E) subgroup was tasked to identify breast cancer screening programme (BCSP) performance indicators, including their acceptable and desirable levels, which are associated w...

Descripción completa

Detalles Bibliográficos
Autores: Muratov, Sergei, Castells, Xavier, Broeders, Mireille, ECIBC Contributor Group
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2020
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10230/47665
Acceso en línea:http://hdl.handle.net/10230/47665
http://dx.doi.org/10.1186/s12885-020-07289-z
Access Level:acceso abierto
Palabra clave:Breast neoplasms/diagnostic imaging
Early detection of Cancer/methods
Female
Health care/standards
Mass screening/methods
Programme evaluation
Quality indicators
id ES_c8a12ba3467cf77a5673cf06c96ac03e
oai_identifier_str oai:recercat.cat:10230/47665
network_acronym_str ES
network_name_str España
repository_id_str
spelling Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicatorsMuratov, SergeiCastells, XavierBroeders, MireilleECIBC Contributor GroupBreast neoplasms/diagnostic imagingEarly detection of Cancer/methodsFemaleHealth care/standardsMass screening/methodsProgramme evaluationQuality indicatorsBackground: In the scope of the European Commission Initiative on Breast Cancer (ECIBC) the Monitoring and Evaluation (M&E) subgroup was tasked to identify breast cancer screening programme (BCSP) performance indicators, including their acceptable and desirable levels, which are associated with breast cancer (BC) mortality. This paper documents the methodology used for the indicator selection. Methods: The indicators were identified through a multi-stage process. First, a scoping review was conducted to identify existing performance indicators. Second, building on existing frameworks for making well-informed health care choices, a specific conceptual framework was developed to guide the indicator selection. Third, two group exercises including a rating and ranking survey were conducted for indicator selection using pre-determined criteria, such as: relevance, measurability, accurateness, ethics and understandability. The selected indicators were mapped onto a BC screening pathway developed by the M&E subgroup to illustrate the steps of BC screening common to all EU countries. Results: A total of 96 indicators were identified from an initial list of 1325 indicators. After removing redundant and irrelevant indicators and adding those missing, 39 candidate indicators underwent the rating and ranking exercise. Based on the results, the M&E subgroup selected 13 indicators: screening coverage, participation rate, recall rate, breast cancer detection rate, invasive breast cancer detection rate, cancers > 20 mm, cancers ≤10 mm, lymph node status, interval cancer rate, episode sensitivity, time interval between screening and first treatment, benign open surgical biopsy rate, and mastectomy rate. Conclusion: This systematic approach led to the identification of 13 BCSP candidate performance indicators to be further evaluated for their association with BC mortality.BioMed Central202120212020info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/47665http://dx.doi.org/10.1186/s12885-020-07289-zreponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)Inglés© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data mahttp://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:recercat.cat:10230/476652026-05-29T05:05:01Z
dc.title.none.fl_str_mv Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
title Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
spellingShingle Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
Muratov, Sergei
Breast neoplasms/diagnostic imaging
Early detection of Cancer/methods
Female
Health care/standards
Mass screening/methods
Programme evaluation
Quality indicators
title_short Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
title_full Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
title_fullStr Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
title_full_unstemmed Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
title_sort Monitoring and evaluation of breast cancer screening programmes: selecting candidate performance indicators
dc.creator.none.fl_str_mv Muratov, Sergei
Castells, Xavier
Broeders, Mireille
ECIBC Contributor Group
author Muratov, Sergei
author_facet Muratov, Sergei
Castells, Xavier
Broeders, Mireille
ECIBC Contributor Group
author_role author
author2 Castells, Xavier
Broeders, Mireille
ECIBC Contributor Group
author2_role author
author
author
dc.subject.none.fl_str_mv Breast neoplasms/diagnostic imaging
Early detection of Cancer/methods
Female
Health care/standards
Mass screening/methods
Programme evaluation
Quality indicators
topic Breast neoplasms/diagnostic imaging
Early detection of Cancer/methods
Female
Health care/standards
Mass screening/methods
Programme evaluation
Quality indicators
description Background: In the scope of the European Commission Initiative on Breast Cancer (ECIBC) the Monitoring and Evaluation (M&E) subgroup was tasked to identify breast cancer screening programme (BCSP) performance indicators, including their acceptable and desirable levels, which are associated with breast cancer (BC) mortality. This paper documents the methodology used for the indicator selection. Methods: The indicators were identified through a multi-stage process. First, a scoping review was conducted to identify existing performance indicators. Second, building on existing frameworks for making well-informed health care choices, a specific conceptual framework was developed to guide the indicator selection. Third, two group exercises including a rating and ranking survey were conducted for indicator selection using pre-determined criteria, such as: relevance, measurability, accurateness, ethics and understandability. The selected indicators were mapped onto a BC screening pathway developed by the M&E subgroup to illustrate the steps of BC screening common to all EU countries. Results: A total of 96 indicators were identified from an initial list of 1325 indicators. After removing redundant and irrelevant indicators and adding those missing, 39 candidate indicators underwent the rating and ranking exercise. Based on the results, the M&E subgroup selected 13 indicators: screening coverage, participation rate, recall rate, breast cancer detection rate, invasive breast cancer detection rate, cancers > 20 mm, cancers ≤10 mm, lymph node status, interval cancer rate, episode sensitivity, time interval between screening and first treatment, benign open surgical biopsy rate, and mastectomy rate. Conclusion: This systematic approach led to the identification of 13 BCSP candidate performance indicators to be further evaluated for their association with BC mortality.
publishDate 2020
dc.date.none.fl_str_mv 2020
2021
2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/47665
http://dx.doi.org/10.1186/s12885-020-07289-z
url http://hdl.handle.net/10230/47665
http://dx.doi.org/10.1186/s12885-020-07289-z
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv http://creativecommons.org/licenses/by/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv http://creativecommons.org/licenses/by/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv BioMed Central
publisher.none.fl_str_mv BioMed Central
dc.source.none.fl_str_mv reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869419302041419776
score 15,81155

Similares en LA Referencia